In a survey of 377 buprenorphine prescribers in Michigan, high-threshold practices such as requiring counseling as a condition for buprenorphine treatment and conducting drug testing during every in-office visit were associated with higher rates of treatment termination for patients receiving buprenorphine. Buprenorphine treatment continuity is critical to preventing overdose deaths amidst an intensifying national overdose crisis. State policy reforms encouraging practices to retain patients in treatment even if they do not strictly adhere to counseling recommendations and limiting drug testing to a clinically relevant frequency could improve overall patient engagement with buprenorphine treatment and save lives.
Published January 16, 2024
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Childhood Lead Exposure Prevention: Assessment Of Blood Lead Surveillance Capacity Maharashtra, India
UK PACT : Enhancing Sustainable Urban Mobility in Surabaya and Makassar
Stage at diagnosis and survival by stage for the leading childhood cancers in…
Short-term association of particulate matter and cardiovascular disease mortality in Shanghai, China between…
Information About New Federal Regulations for Opioid Treatment Programs (OTPs)
Centering Country Ownership and Leadership: The Data for Health Initiative’s Approach
Mass Media Campaigns
Tobacco Imagery in Movies and Web Series Streaming in India and Their Compliance…
Data for Health: Advancing Gender Equity
The Index of Tobacco Control Sustainability